Liquid biopsy for breast cancer using extracellular vesicles and cell-free microRNAs as biomarkers

被引:39
作者
Murobushi Ozawa, Patricia Midori [1 ]
Jucoski, Tayana Schultz [1 ]
Vieira, Evelyn [1 ]
Carvalho, Tamyres Mingorance [1 ]
Malheiros, Danielle [1 ]
De Souza Fonseca Ribeiro, Enilze Maria [1 ]
机构
[1] Univ Fed Parana, Genet Dept, Postgrad Program Genet, Curitiba, Parana, Brazil
关键词
CIRCULATING MICRORNAS; DRUG-RESISTANCE; SERUM MICRORNA; NEOADJUVANT CHEMOTHERAPY; POTENTIAL BIOMARKER; PROGNOSTIC VALUE; EXPRESSION; EXOSOMES; PLASMA; MICROVESICLES;
D O I
10.1016/j.trsl.2020.04.002
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Improvement of breast cancer (BC) patient's outcome is directly related to early detection. However, there is still a lack of reliable biomarkers for diagnosis, prognosis and, treatment follow up in BC, leading researchers to study the potential of liquid biopsy based on circulating microRNAs (c-miRNAs). These c-miRNAs can be cell-free or associated with extracellular vesicles (EVs), and have great advantages such as stability in biofluids, noninvasive accessibility compared to current techniques (core-biopsy and surgery), and expression associated with pathogenic conditions. Recently, a new promising field of EV-derived miRNAs (EV-miRNAs) as cancer biomarkers has emerged, receiving special attention due to their selective vesicle sorting which makes them accurate for disease detection. In this review, we discuss new findings about c-miRNA and their potential as biomarkers for BC diagnosis, prognosis, and therapy. Additionally, we address the impact of limitations associated with the standardization of analysis techniques and methods on the implementation of these biomarkers in the clinical setting.
引用
收藏
页码:40 / 60
页数:21
相关论文
共 140 条
[1]   MiR 221/222 as New Players in Tamoxifen Resistance [J].
Alamolhodaei, Nafiseh Sadat ;
Behravan, Javad ;
Mosaffa, Fatemeh ;
Karimi, Gholamreza .
CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (46) :6946-6955
[2]   The functions of animal microRNAs [J].
Ambros, V .
NATURE, 2004, 431 (7006) :350-355
[3]   Circulating miR-200c and miR-141 and outcomes in patients with breast cancer [J].
Antolin, Silvia ;
Calvo, Lourdes ;
Blanco-Calvo, Moises ;
Paz Santiago, Maria ;
Jose Lorenzo-Patino, Maria ;
Haz-Conde, Mar ;
Santamarina, Isabel ;
Figueroa, Angelica ;
Miguel Anton-Aparicio, Luis ;
Valladares-Ayerbes, Manuel .
BMC CANCER, 2015, 15
[4]   Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma [J].
Arroyo, Jason D. ;
Chevillet, John R. ;
Kroh, Evan M. ;
Ruf, Ingrid K. ;
Pritchard, Colin C. ;
Gibson, Donald F. ;
Mitchell, Patrick S. ;
Bennett, Christopher F. ;
Pogosova-Agadjanyan, Era L. ;
Stirewalt, Derek L. ;
Tait, Jonathan F. ;
Tewari, Muneesh .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (12) :5003-5008
[5]   New emerging roles of microRNAs in breast cancer [J].
Ayerim Mandujano-Tinoco, Edna ;
Garcia-Venzor, Alfredo ;
Melendez-Zajgla, Jorge ;
Maldonado, Vilma .
BREAST CANCER RESEARCH AND TREATMENT, 2018, 171 (02) :247-259
[6]   Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts [J].
Baroni, S. ;
Romero-Cordoba, S. ;
Plantamura, I. ;
Dugo, M. ;
D'Ippolito, E. ;
Cataldo, A. ;
Cosentino, G. ;
Angeloni, V. ;
Rossini, A. ;
Daidone, M. G. ;
Iorio, M. V. .
CELL DEATH & DISEASE, 2016, 7 :e2312-e2312
[7]   Nanotubes, exosomes, and nucleic acid-binding peptides provide novel mechanisms of intercellular communication in eukaryotic cells: implications in health and disease [J].
Belting, Mattias ;
Wittrup, Anders .
JOURNAL OF CELL BIOLOGY, 2008, 183 (07) :1187-1191
[8]   Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer [J].
Bovy, Nicolas ;
Blomme, Benoit ;
Freres, Pierre ;
Dederen, Stella ;
Nivelles, Olivier ;
Lion, Michelle ;
Carnet, Oriane ;
Martial, Joseph A. ;
Noel, Agnes ;
Thiry, Marc ;
Jerusalem, Guy ;
Josse, Claire ;
Bours, Vincent ;
Tabruyn, Sebastien P. ;
Struman, Ingrid .
ONCOTARGET, 2015, 6 (12) :10253-10266
[9]   Triple-negative breast cancer in the older population [J].
Boyle, P. .
ANNALS OF ONCOLOGY, 2012, 23 :7-12
[10]   Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial [J].
Bramwell, Vivien H. C. ;
Tuck, Alan B. ;
Chapman, Judith-Anne W. ;
Anborgh, Pieter H. ;
Postenka, Carl O. ;
Al-Katib, Waleed ;
Shepherd, Lois E. ;
Han, Lei ;
Wilson, Carolyn F. ;
Pritchard, Kathleen I. ;
Pollak, Michael N. ;
Chambers, Ann F. .
BREAST CANCER RESEARCH, 2014, 16 (01)